GoAI
Get started
Guangdong Kanghua Healthcare Group Co., Ltd. logo

Guangdong Kanghua Healthcare Group Co., Ltd.

3689.HK

HKSEHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

HK$1.655

−HK$0.13 · -7.28%

Aug 21, 6:09 PM HKT

3689.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Guangdong Kanghua Healthcare Group Co., Ltd. primarily operates private hospitals in the People's Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services. The company also offers reproductive medicine; plastic and aesthetic surgery; and laser treatment services. In addition, it provides rehabilitation services to patients with physical or mental disabilities; treatments that replicate kidney's function to remove wastes in blood for patients with kidney conditions; and other healthcare-related services, including elderly care and training service for the disabled. Further, the company offers elderly healthcare services, including assisted living, adult daycare, long-term care, residential care, and hospice care to the aged patients. Additionally, it operates Kanghua Hospital, Renkang Hospital, and Kangxin Hospital names; and offers management, hospital management, and property holding services. Guangdong Kanghua Healthcare Group Co., Ltd. was formerly known as Guangdong Kanghua Healthcare Co., Ltd. and changed its name to Guangdong Kanghua Healthcare Group Co., Ltd. in August 2024. The company was incorporated in 2002 and is based in Dongguan, China. Guangdong Kanghua Healthcare Group Co., Ltd. operates as a subsidiary of Dongguan Kanghua Investment Group Co., Ltd.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
CN
CEO
Wang Zhi Chen
Listed since
Nov 8, 2016
Employees
3,728

Market position

Day range

Current HK$1.655

52-week range

Current HK$1.655

Open
HK$1.655
Previous close
HK$1.785
Volume
14.2K
1.5× average
Average volume
9.44K
Average daily volume
Market cap
553.42M HKD
Beta
0.46
Market reference 1
50-day average
HK$1.7688
-6.43% below average
200-day average
HK$1.8687
-11.43% below average

Financials

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends20%13%6%-1%Gross margin, FY2021: 18.05%Gross margin, FY2022: 14.16%Gross margin, FY2023: 17.85%Gross margin, FY2024: 15.66%Gross margin, FY2025: 18.23%Operating margin, FY2021: 7.59%Operating margin, FY2022: 1.52%Operating margin, FY2023: 5.95%Operating margin, FY2024: 2.23%Operating margin, FY2025: 5.78%Net margin, FY2021: 4.83%Net margin, FY2022: 3.23%Net margin, FY2023: 5.93%Net margin, FY2024: 0.75%Net margin, FY2025: 4.92%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 18.05%. Gross margin FY2022 14.16%. Gross margin FY2023 17.85%. Gross margin FY2024 15.66%. Gross margin FY2025 18.23%. Operating margin FY2021 7.59%. Operating margin FY2022 1.52%. Operating margin FY2023 5.95%. Operating margin FY2024 2.23%. Operating margin FY2025 5.78%. Net margin FY2021 4.83%. Net margin FY2022 3.23%. Net margin FY2023 5.93%. Net margin FY2024 0.75%. Net margin FY2025 4.92%.

Income trends

Revenue

1.97B HKD-4.08%

Operating income

113.93M HKD+148.15%

Net income

97.01M HKD+532.55%
Income trends across reported periods2.26B HKD1.44B HKD627.44M HKD−188.7M HKDRevenue, FY2021: 1.95B HKDRevenue, FY2022: 1.85B HKDRevenue, FY2023: 2.04B HKDRevenue, FY2024: 2.06B HKDRevenue, FY2025: 1.97B HKDOperating income, FY2021: 148.38M HKDOperating income, FY2022: 28.14M HKDOperating income, FY2023: 121.49M HKDOperating income, FY2024: 45.91M HKDOperating income, FY2025: 113.93M HKDNet income, FY2021: 94.31M HKDNet income, FY2022: 59.7M HKDNet income, FY2023: 121.06M HKDNet income, FY2024: 15.34M HKDNet income, FY2025: 97.01M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.95B HKD. Revenue FY2022 1.85B HKD. Revenue FY2023 2.04B HKD. Revenue FY2024 2.06B HKD. Revenue FY2025 1.97B HKD. Operating income FY2021 148.38M HKD. Operating income FY2022 28.14M HKD. Operating income FY2023 121.49M HKD. Operating income FY2024 45.91M HKD. Operating income FY2025 113.93M HKD. Net income FY2021 94.31M HKD. Net income FY2022 59.7M HKD. Net income FY2023 121.06M HKD. Net income FY2024 15.34M HKD. Net income FY2025 97.01M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue1.97B HKD2.06B HKD2.04B HKD1.85B HKD1.95B HKD
Cost of goods sold1.61B HKD1.73B HKD1.68B HKD1.58B HKD1.6B HKD
Gross profit359.37M HKD321.87M HKD364.37M HKD261.35M HKD352.75M HKD
Research and development1.55M HKD904.24K HKD650.84K HKD1.1M HKD835K HKD
Selling, general, and administrative207.43M HKD277.1M HKD242.39M HKD228.32M HKD225.22M HKD
Operating expenses245.44M HKD275.96M HKD242.88M HKD222.59M HKD214.04M HKD
Interest income10.03M HKD6M HKD4.92M HKD3.23M HKD1.87M HKD
Interest expense15.55M HKD11.95M HKD12.06M HKD15.04M HKD19.81M HKD
Depreciation and amortization135.85M HKD149.86M HKD143.08M HKD149.44M HKD149.44M HKD
Operating income113.93M HKD45.91M HKD121.49M HKD28.14M HKD148.38M HKD
Net income97.01M HKD15.34M HKD121.06M HKD59.7M HKD94.31M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
0.19

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.270.150.02-0.1Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q2 '25Q1 '26
Q3 2022, reported Aug 30, 2022: actual -0.017, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 31, 2023: actual 0.22, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 31, 2023: actual 0.163, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 28, 2024: actual 0.232, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 30, 2024: actual -0.063, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual 0.106, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 26, 2025: actual 0.131, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 31, 2026: actual 0.189, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.94B1.61B1.27B935.24MQ3 '22MissQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24No estimateQ1 '25No estimateQ2 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 30, 2022: actual 1.01B HKD, estimate 1.87B HKD, surprise -45.93%, Miss. Q1 2023, reported Mar 31, 2023: actual 1.12B HKD, estimate 1.87B HKD, surprise -40.07%, Miss. Q3 2023, reported Aug 31, 2023: actual 1.07B HKD, estimate 1.87B HKD, surprise -42.83%, Miss. Q1 2024, reported Mar 28, 2024: actual 1.17B HKD, estimate 1.87B HKD, surprise -37.53%, Miss. Q3 2024, reported Aug 30, 2024: actual 1.06B HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual 1.14B HKD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 26, 2025: actual 1.07B HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 31, 2026: actual 1.14B HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.16

2025 complete year0.0% since 2017

2026 partial: HK$0.19

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Jun 23, 2026

HK$0.19

Annual

Record Jun 24, 2026 · Payment Jul 31, 2026

Dividend

Ex-dividend Jun 23, 2025

HK$0.16

Annual

Record Jun 24, 2025 · Payment Jul 25, 2025

Dividend

Ex-dividend Jun 17, 2019

HK$0.18

Annual

Record Jun 18, 2019 · Payment Jul 23, 2019

Dividend

Ex-dividend Jun 12, 2018

HK$0.20

Annual

Record Jun 13, 2018 · Payment Jul 20, 2018

Dividend

Ex-dividend Jun 12, 2017

HK$0.16

Annual

Record Jun 13, 2017 · Payment Jul 19, 2017

3689.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.7

-3.94%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.46

-3.61%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$221.4

-2.89%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.60

-4.71%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.06

-6.11%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$99.50

-2.83%

Continue in GoAI

Research 3689.HK

research.disclaimer